BrightSpring Health Services (BTSG) 2026 Jefferies Healthcare Services and Technology Conference summary

Business performance and market positioning

• Maintains strong performance across home and community healthcare, targeting both pharmacy and provider businesses in high-demand markets.

• Leverages a unified operational playbook and infrastructure to drive quality and innovation across all segments.

• Focuses on broad-based, double-digit growth, supported by technology and talent investments.

Growth drivers and specialty pharmacy outlook

• Specialty pharmacy growth is driven by generics, LDDs, and partnerships with biotech and pharma, with 20+ new launches annually.

• Anticipates several major brand-to-generic conversions next year, providing ongoing growth opportunities.

• Recognized for high service quality, with Net Promoter Scores reaching 100 from doctors and patients.

• Recent LDD wins, such as REVLIMID, expected to be tailwinds for next year.

Financial performance and profitability

• Gross profit per script is stable, with expected increases in gross profit dollars and EBITDA in Q3 and Q4.

• Operates one of the largest pharmacy businesses in the US, processing over 40 million scripts annually.

• Focuses on EBITDA and cash flow growth, with over $600 million in operating cash flow and $500 million in free cash flow projected this year.